VANCOUVER, British Columbia, July 13, 2021 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated developer of mushroom products is pleased to announce its inclusion in the first psychedelics Exchange Traded Fund (“ETF”) (NEO: PSYK). The ETF began trading on the Neo Exchange as of January 26, 2021. The ETF invests in…

Source

Previous articleActive vs. Passive Coping Distinguishes Antidepressants and Psychedelics
Next articleIan Burnstein Joins Wesana Health Advisory Board